Use of Cancer Genetics Services in African-American Young Breast Cancer Survivors

American Journal of Preventive Medicine

Volumn 51, Issue 4, 2016, Pages 427-436

  Jones, Tarsha ^a,b   Lockhart, Joan S ^b   Mendelsohn Victor, Kari E ^c   Duquette, Debra ^d   Northouse, Laurel L ^c   Duffy, Sonia A ^e   Donley, Rosemary ^b   Merajver, Sofia D ^f   Milliron, Kara J ^g   Roberts, J Scott ^h   Katapodi, Maria C ^c,i  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b DUQUESNE UNIVERSITY   (United States)

^c UNIVERSITY OF MICHIGAN SCHOOL OF NURSING   (United States)

^d Cancer Genomics Program   (United States)

^e OHIO STATE UNIVERSITY   (United States)

^f UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^g UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^h UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

ⁱ UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER GENETICS; CANCER REGISTRY; CANCER SURVIVOR; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; GENETIC SERVICE; HEALTH CARE COST; HEALTH SERVICE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PATIENT-REPORTED OUTCOME; RANDOMIZED CONTROLLED TRIAL; TUMOR INVASION; ATTITUDE TO HEALTH; BREAST TUMOR; ETHNOLOGY; GENETICS; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; TUMOR GENE; UTILIZATION;

ADULT; AFRICAN AMERICANS; BREAST NEOPLASMS; CANCER SURVIVORS; FEMALE; GENES, NEOPLASM; GENETIC TESTING; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MIDDLE AGED;

EID: 84973121828     PISSN: 07493797     EISSN: 18732607     Source Type: Journal    
DOI: 10.1016/j.amepre.2016.03.016     Document Type: Article

References (46)

1. 1 Daly, B., Olopade, O.I., A perfect storm: how tumor biology, genomics, and health care delivery patterns collide to create a racial survival disparity in breast cancer and proposed interventions for change. CA Cancer J Clin 65:3 (2015), 221–238, 10.3322/caac.21271.
2. 2 Danforth, D.N., Disparities in breast cancer outcomes between Caucasian and African American women: a model for describing the relationship of biological and non-biological factors. Breast Cancer Res Treat, 15(3), 2013, 208, 10.1186/bcr3429.
3. 3 McCarthy, A.M., Yang, J., Armstrong, K., Increasing disparities in breast cancer mortality from 1979 to 2010 for U.S. black women aged 20 to 49 years. Am J Public Health 105:suppl 3 (2015), S446–S448, 10.2105/AJPH.2014.302297.
4. 4 Rosenberg, S.M., Newman, L.A., Partridge, A.H., Breast cancer in young women: rare disease or public health problem?. JAMA Oncol 7 (2015), 877–878, 10.1001/jamaoncol.2015.2112.
5. 5 Ashing-Giwa, K., Tapp, C., Brown, S., et al. Are survivorship care plans responsive to African-American breast cancer survivors?: voices of survivors and advocates. J Cancer Surv 7:3 (2013), 283–291, 10.1007/s11764-013-0270-1.
6. 6 Brewster, A.M., Chavez-MacGregor, M., Brown, P., Epidemiology, biology, and treatment of triple-negative breast cancer in women of African ancestry. Lancet Oncol 15:13 (2014), e625–e634, 10.1016/S1470-2045(14)70364-X.
7. 7 Churpek, J.E., Walsh, T., Zheng, Y., et al. Inherited predisposition to breast cancer among African American women. Breast Cancer Res Treat 149:1 (2015), 31–39, 10.1007/s10549-014-3195-0.
8. 8 Newman, L.A., Disparities in breast cancer and African ancestry: a global perspective. Breast J 21:2 (2015), 133–139, 10.1111/tbj.12369.
9. 9 Couch, F.J., Nathanson, K.L., Offit, K., Two decades after BRCA: setting paradigms in personalized cancer care and prevention. Science 343:6178 (2014), 1466–1470, 10.1126/science.1251827.
10. 10 Balmana, J., Diez, O., Rubio, I.T., Cardoso, F., ESMO Guidelines Working Group. BRCA in breast cancer: ESMO clinical practice guidelines. Ann Oncol 22:suppl 6 (2011), vi31–vi34, 10.1093/annonc/mdr373.
11. 11 King, M., Levy-Lahad, E., Lahad, A., Population-based screening for BRCA1 and BRCA2: 2014 Lasker award. JAMA 312:11 (2014), 1091–1092, 10.1001/jama.2014.12483.
12. 12 Malone, K.E., Begg, C.B., Haile, R.W., et al. Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2. J Clin Oncol 28:14 (2010), 2404–2410, 10.1200/JCO.2009.24.2495.
13. 13 National Comprehensive Cancer Network (NCCN). Genetic/familial high-risk assessment: breast and ovarian. Version 2. 2016. www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf.
14. 14 Hall, M., Olopade, O.I., Confronting genetic testing disparities: knowledge is power. JAMA 293:14 (2005), 1783–1785, 10.1001/jama.293.14.1783.
15. 15 Armstrong, K., Micco, E., Carney, A., Stopfer, J., Putt, M., Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. JAMA 293:14 (2005), 1729–1736, 10.1001/jama.293.14.1729.
16. 16 Cragun, D., Bonner, D., Kim, J., et al. Factors associated with genetic counseling and BRCA testing in a population-based sample of young black women with breast cancer. Breast Cancer Res Treat 151:1 (2015), 169–176, 10.1007/s10549-015-3374-7.
17. 17 Pal, T., Bonner, D., Cragun, D., et al. A high frequency of BRCA mutations in young black women with breast cancer residing in Florida. Cancer 121:23 (2015), 4173–4180, 10.1002/cncr.29645.
18. 18 Pal, T., Bonner, D., Kim, J., et al. Early onset breast cancer in a registry‐based sample of African‐American women: BRCA mutation prevalence, and other personal and system‐level clinical characteristics. Breast J 19:2 (2013), 189–192, 10.1111/tbj.12083.
19. 19 Pal, T., Bonner, D., Cragun, D., et al. BRCA sequencing and large rearrangement testing in young black women with breast cancer. J Community Genet 5:2 (2014), 157–165, 10.1007/s12687-013-0166-9.
20. 20 Sheppard, V.B., Mays, D., LaVeist, T., Tercyak, K.P., Medical mistrust influences black women's level of engagement in BRCA 1/2 genetic counseling and testing. J Natl Med Assoc 105:1 (2013), 17–22, 10.1016/S0027-9684(15)30081-X.
21. 21 Jagsi, R., Griffith, K.A., Kurian, A.W., et al. Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer. J Clin Oncol 33:14 (2015), 1584–1591, 10.1200/JCO.2014.58.5885.
22. 22 Armstrong, K., Weber, B., Stopfer, J., et al. Early use of clinical BRCA1/2 testing: associations with race and breast cancer risk. Am J Med Genet A 117:2 (2003), 154–160, 10.1002/ajmg.a.10928.
23. 23 Frank, T.S., Deffenbaugh, A.M., Reid, J.E., et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20:6 (2002), 1480–1490, 10.1200/JCO.20.6.1480.
24. 24 Levy, D.E., Byfield, S.D., Comstock, C.B., et al. Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk. Genet Med 13:4 (2011), 349–355, 10.1097/GIM.0b013e3182091ba4.
25. 25 Sheppard, V.B., Graves, K.D., Christopher, J., Hurtado-de-Mendoza, A., Talley, C., Williams, K.P., African American women's limited knowledge and experiences with genetic counseling for hereditary breast cancer. J Genet Couns 23:3 (2014), 311–322, 10.1007/s10897-013-9663-6.
26. 26 Adams, I., Christopher, J., Williams, K.P., Sheppard, V.B., What black women know and want to know about counseling and testing for BRCA1/2. J Cancer Educ 30:2 (2015), 344–352, 10.1007/s13187-014-0740-9.
27. 27 Glenn, B.A., Chawla, N., Bastani, R., Barriers to genetic testing for breast cancer risk among ethnic minority women: an exploratory study. Ethn Dis 22:3 (2012), 267–273.
28. 28 Pal, T., Permuth-Wey, J., Holtje, T., Sutphen R. BRCA1 and BRCA2 mutations in a study of African American breast cancer patients. Cancer Epidemiol Biomarkers Prev 13:11 Pt 1 (2004), 1794–1799.
29. 29 Katapodi, M.C., Northouse, L.L., Schafenacker, A.M., et al. Using a state cancer registry to recruit young breast cancer survivors and high-risk relatives: protocol of a randomized trial testing the efficacy of a targeted versus a tailored intervention to increase breast cancer screening. BMC Cancer, 13, 2013, 97, 10.1186/1471-2407-13-97.
30. 30 Ajzen, I., The theory of planned behavior. Organ Behav Hum Decis Process 50:2 (1991), 179–211, 10.1016/0749-5978(91)90020-T.
31. 31 Katapodi, M.C., Northouse, L.L., Milliron, K.J., Liu, G., Merajver, S.D., Individual and family characteristics associated with BRCA1/2 genetic testing in high‐risk families. Psychooncology 22:6 (2013), 1336–1343, 10.1002/pon.3139.
32. 32 Ajzen, I., The theory of planned behavior: reactions and reflections. Psychol Health 26:9 (2011), 1113–1127, 10.1080/08870446.2011.613995.
33. 33 Taymoori, P., Moshki, M., Roshani, D., Facilitator psychological constructs for mammography screening among Iranian women. Asian Pac J Cancer Prev 15:17 (2014), 7309–7316, 10.7314/APJCP.2014.15.17.7309.
34. 34 Forbes, C.C., Blanchard, C.M., Mummery, W.K., Courneya, K., Prevalence and correlates of strength exercise among breast, prostate, and colorectal cancer survivors. Oncol Nurs Forum 42:2 (2015), 118–127, 10.1188/15.ONF.42-02AP.
35. 35 Trinh, L., Mutrie, N., Campbell, A.M., Crawford, J.J., Courneya, K.S., Effects of supervised exercise on motivational outcomes in breast cancer survivors at 5-year follow-up. Eur J Oncol Nurs 18:6 (2014), 557–563, 10.1016/j.ejon.2014.07.004.
36. 36 CDC. Behavorial risk factor surveillance system (BRFSS). www.cdc.gov/brfss/. Updated 2015. Accessed October 15, 2015.
37. 37 Anderson, B., McLosky, J., Wasilevich, E., Lyon-Callo, S., Duquette, D., Copeland, G., Barriers and facilitators for utilization of genetic counseling and risk assessment services in young female breast cancer survivors. J Cancer Epidemiol, 2012, 2012, 298745, 10.1155/2012/298745.
38. 38 Michigan Department of Health and Human Services. Michigan BRFS annual questionnaires. www.michigan.gov/mdhhs/0,5885,7-339-71550_5104_5279_39424_39425-263911-00.html. Updated 2015. Accessed October 2015.
39. 39 Halbert, C.H., Kessler, L., Collier, A., et al. Low rates of African American participation in genetic counseling and testing for BRCA1/2 mutations: racial disparities or just a difference?. J Genet Couns 21:5 (2012), 676–683, 10.1007/s10897-012-9485-y.
40. 40 Pal, T., Rocchio, E., Garcia, A., Rivers, D., Vadaparampil, S., Recruitment of black women for a study of inherited breast cancer using a cancer registry−based approach. Genet Test Mol Biomarkers 15:1-2 (2011), 69–77, 10.1089/gtmb.2010.0098.
41. 41 Bellcross, C.A., Peipins, L.A., McCarty, F.A., et al. Characteristics associated with genetic counseling referral and BRCA1/2 testing among women in a large integrated health system. Genet Med 17:1 (2014), 43–50, 10.1038/gim.2014.68.
42. 42 Peters, N., Domchek, S.M., Rose, A., Polis, R., Stopfer, J., Armstrong, K., Knowledge, attitudes, and utilization of BRCA1/2 testing among women with early-onset breast cancer. Genet Test 9:1 (2005), 48–53, 10.1089/gte.2005.9.48.
43. 43 Ruddy, K.J., Gelber, S., Shin, J., et al. Genetic testing in young women with breast cancer: results from a web-based survey. Ann Oncol 21:4 (2010), 741–747, 10.1093/annonc/mdp355.
44. 44 Vadaparampil, S.T., Pal, T., Updating and refining a study brochure for a cancer registry-based study of BRCA mutations among young African American breast cancer patients: lessons learned. J Community Genet 1:2 (2010), 63–71, 10.1007/s12687-010-0010-4.
45. 45 Permuth‐Wey, J., Vadaparampil, S., Rumphs, A., Kinney, A.Y., Pal, T., Development of a culturally tailored genetic counseling booklet about hereditary breast and ovarian cancer for black women. Am J Med Genet A 152:4 (2010), 836–845, 10.1002/ajmg.a.33187.
46. 46 Kinney, A.Y., Simonsen, S.E., Baty, B.J., et al. Acceptance of genetic testing for hereditary breast ovarian cancer among study enrollees from an African American kindred. Am J Med Genet A 140:8 (2006), 813–826, 10.1002/ajmg.a.31162.